Clinical trial
Home-based Transcranial Alternating Current Stimulation (tACS) for Older Adults at Risk of Memory Decline
NCT04783350 is registered in ClinicalTrials.gov with Hebrew SeniorLife as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Home-based Transcranial Alternating Current Stimulation (tACS) for Older Adults at Risk of Memory Decline
- Lead sponsor
- Hebrew SeniorLife
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 6, 2020
- Completion date
- September 30, 2023
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, memory loss